nctId: NCT06290635 id: Pro00119668 briefTitle: Edmonton Dyspnea Inventory- Validation Study overallStatus: ACTIVE_NOT_RECRUITING date: 2022-11-11 date: 2024-05-30 date: 2024-12-30 date: 2024-03-04 date: 2024-04-11 name: University of Alberta class: OTHER briefSummary: Breathlessness is a common problem for many patients with Interstitial lung disease (ILD). ILD is a group of lung diseases that cause inflammation (swelling) and scarring in the lung tissue where gas exchange (oxygen and carbon dioxide) occurs. Unfortunately, there is no cure for these conditions and as a result many patients decline over time with worsening breathlessness. This limits their ability to live a good life. Clinicians do not often recognize, assess, or treat breathlessness appropriately. Breathlessness, being a subjective experience, cannot be fully understood through objective measurements such as lung function tests, the arterial blood gas test etc. The objective and subjective measures of breathlessness are frequently disconnected. Clinicians who often rely on these types of objective tests do not directly enquire into its nature and severity of breathlessness from patients themselves. As a result, they remain unaware of this disabling symptom and the extent of its impact on patients. While there are many tools to measure breathlessness, they are not consistently used in routine care or have impacted care in a meaningful way. Many such tools are also complex with intricate response systems with possibility of errors and user fatigue. As a result, easy to use tools like modified MRC or MRC are frequently used even though they do not assess severity of breathlessness. No tool has been effective at helping clinicians identify the problem and prescribe appropriate treatments. This results in needless suffering for patients and their families and prevents them from receiving timely and appropriate therapies. Investigators propose to test an easy-to-use tool that combines the subjective and objective aspects of breathlessness. Investigators hope that the tool will help clinicians quickly identify the patient's breathlessness severity and provide them with an algorithm of what to do next. The tool was developed by clinicians with +15 years of experience in ILD and dyspnea. Early analysis already suggests the tool is useful to patients and helps improve care. conditions: ILD studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 100 type: ESTIMATED name: Breathlessness Assessment Tool measure: Validate Edmonton Dyspnea Inventory (EDI; formerly known as multidimensional dyspnea scale-MDDS) measure: To perform time-motion observation of care providers or patients using the scale measure: Calculate MCID for Edmonton Dyspnea Inventory measure: Feasibility of Questionnaire measure: To assess day-to-day variability in dyspnea scores sex: ALL minimumAge: 18 Years maximumAge: 90 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Kaye Edmonton Clinic city: Edmonton state: Alberta zip: T6G 2G3 country: Canada lat: 53.55014 lon: -113.46871 facility: Aarhus University city: Aarhus country: Denmark lat: 56.15674 lon: 10.21076 facility: Bristol ILD Service; North Bristol NHS Trust city: Bristol country: United Kingdom lat: 51.45523 lon: -2.59665 hasResults: False